EU-GMP Approval from Hungary for Cephalosporin and Oncology Facilities

CIN No. L24232PB1983PLC005426 GST No. 03AAACK6458M1ZB Phone : 91-8558820862 (Accounts) : 91-8558820863 (Admin.) 0 - ® D.L. No. 1800-0SP, 1804-B I.E. Code No. 1293001210 : 91-9915743720 (Exports) KWALITY PHARMACEUTICALS LIMITED M.D. Mobile: 91-9814071215, 9814052314 E-mail : export©kwalitypharma.com Regd. Office: Village Nag KaIan, Majitha Road, Amritsar - 143 601 (INDIA) ramesh©kwalitypharma.com Website : www.kwalitypharma.com Date: November 04, 2026 Department of Corporate Services, BSE Limited 25th Floor, P.J. Towers, Dalal Street Mumbai-400001 Scrip Code: 539997 Subject : Kwality Pharmaceuticals Limited Secures EU-GMP Approval from Hungary for Cephalosporin and Oncology Facilities Dear Sir/Madam, We are pleased to announce that Kwality Pharmaceuticals Ltd. has further strengthened its regulatory credentials with EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities, complementing our earlier EU-GMP approval from Bulgaria. This milestone significantly expands our EU-GMP-approved manufacturing capabilities across specialised pharmaceutical segments, strengthening our competitive positioning in highly regulated markets. It is expected to create substantial business opportunities by attracting new licensing opportunities. accelerate product registrations and improve our competitiveness in high-value global markets. This achievement marks another important step towards expanding our international footprint and driving sustainable business growth. For Kwality Pharmace Ramesh Kumar Managing Director DIN: 00462656